期刊文献+

复合异丙酚时瑞芬太尼抑制维吾尔族患者气管插管及切皮反应的半数有效血浆浓度 被引量:10

Median effective plasma concentration of remifentanil inhibiting cardiovascular response to tracheal intubation and skin incision when combined with propofol in patients of Uighur nationality
原文传递
导出
摘要 目的确定复合异丙酚时瑞芬太尼抑制维吾尔族患者气管插管及切皮反应的半数有效血浆浓度(EC50)。方法择期拟行腹腔镜胆囊切除术维吾尔族患者30例,ASA分级Ⅰ或Ⅱ级,年龄20.60岁,体重指数18-30kg/m2。静脉输注异丙酚维持BIS值40—50时,TCI瑞芬太尼,初始Cp6.0ng/ml,待Ce与Cp达平衡后静脉注射顺式阿曲库铵0.2mg/kg,2min后行气管插管。患者气管插管后初始Cp为6.0ng/ml,待Ce与Cp达平衡后开始切皮。发生气管插管反应和(或)切皮反应,则下一例患者采用高一级浓度,否则采用低一级浓度,浓度梯度为0.5ng/ml。发生气管插管反应和(或)切皮反应的标准:收缩压升高超过基础值15%和(或)心率〉90次/min且持续时间〉15s。计算瑞芬太尼抑制气管插管及切皮反应的EC50及其95%可信区间(CI)。结果复合异丙酚维持BIS值40~50时瑞芬太尼抑制气管插管及切皮反应的EC50及其95%CI分别为3.4(2.3—4.5)ng/ml和3.8(2.8~4.9)ng/ml。结论复合异丙酚维持BIS值40-50时瑞芬太尼抑制维吾尔族患者气管插管及切皮反应的EC50分别为3.4和3.8ng/ml。 Objective To determine the median effective plasma concentration of remifentanil (EC50) inhibiting cardiovascular response to tracheal intubation and skin incision when combined with propofol in patients of Uighur nationality. Methods Thirty ASA Ⅰ or Ⅱ Uighurs aged 20-60 yr with body mass index of 18-30 kg/m2 undergoing elective laparoscopic eholecystectomy were enrolled in this study. Anesthesia was induced and maintained with pmpofol infusion. BIS value was maintained at 40-50. TCI of remifentanil was then started. The initial target plasma concentration (Cp) was 6.0 ng/ml. EC50 of remifentanil was determined by modified Dixon' s up- and-down sequential experiment. Each time Cp increased/decreased by 0.5 ng/ml. Tracheal intubation was facilitated with cisatracurium 0.2 mg/kg at 2 min after a new Cp was set when target effect-site concentration (Ce) was balanced with Cp. Positive cardiovascular response was defined as increase in SBP by 15% and/or HR 〉 90 bpm lastings〉 15 s. The EC50 (95% confidence interval) of remifentanil blunting responses to tracheal intubation and skin incision was calculated. Results EC50 (95 % confidence interval) of remifentanil inhibiting cardiovascular response to tracheal intubation and skin incision when combined with p ropofol was 3.4 (2.3-4.5) ng/ml and 3.8 (2.8-4.9) ng/ml respectively. Conclusion When depth of anesthesia was maintained at BIS value 40-50 with propofol infusion, the EC50 of remifentanil inhibiting cardiovascular response to tracheal intubation and skin incision is 3.4 and 3.8 ng/ml respectively.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2012年第1期54-56,共3页 Chinese Journal of Anesthesiology
关键词 哌啶类 维吾尔族 二异丙酚 剂量效应关系 药物 药物释放系统 Piperidines Uygur nationality Propofol Dose-response relationship, drug Drug deivery systems
  • 相关文献

参考文献3

二级参考文献21

  • 1张加强,邢玉英,杜文力,王明霞,李力兵,付建峰.瑞芬太尼靶控输注时靶浓度和实测血药浓度的差异-靶控输注系统的性能评价[J].中华麻醉学杂志,2005,25(9):645-648. 被引量:18
  • 2薛昀,吴新民.靶控输注瑞芬太尼或芬太尼对术前病人异丙酚镇静作用的影响[J].中华麻醉学杂志,2005,25(10):729-732. 被引量:21
  • 3陈勇,梁敏,欧阳碧山,周德华,刘镭.异丙酚麻醉下瑞芬太尼抑制病人气管插管和切皮时心血管反应的效应室靶浓度[J].中华麻醉学杂志,2007,27(1):28-31. 被引量:21
  • 4Milne SE,Troy A,Irwin MG,et al.Relationship between bispectral index,auditory evoked potential index and effect-site EC50 for propofol at two clinical end-points.Br J Anaesth,2003,90(2):127-131.
  • 5Trabold F,Casetta M,Duranteau J,et al.Propofol and remifentanil for intubation without muscle relaxant:the effect of the order of injection.Acta Anaesthesiol Scand,2004,48(1):35-39.
  • 6Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid:remifentanil (G187094B). Anesth Analg,1993, 77: 1031-1040.
  • 7Glass PS, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg, 1999, 89 Suppl: s7-s14.
  • 8Jhavefi R, Joshi P, Batenhorst R, et al. Dose comparison of remifentanil and alfentanil for loss of consciousness. Anesthesiology, 1997, 87: 253-259.
  • 9Conway DH, Hasan SK, Simpson ME, et al. Target-contrelled propofol requirements at induction of anaesthesia: effect of remifentanil and midazolam.Eur J Anaestbesiol,2002.19:580-584.
  • 10Mertens MJ.Olofsen E.Enghers FH.et al.Propofol reduces perioperative remifentanil requirements in a synergiastic manner:response surface modeling of perioperative remifentanil-propofol interactions.Anesthesiology,2003.99:347-359.

共引文献64

同被引文献78

引证文献10

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部